N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)

References

• Alamia, A., C. Timmermann, D. J. Nutt, R. VanRullen, and R. L. Carhart-Harris. 2020. DMT alters cortical travelling waves. Elife 9. doi:10.7554/eLife.59784.
   Web of Science ®Google Scholar
• Aqil, M., and L. Roseman. 2023. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics. Neuropharmacology 223:109300. doi:10.1016/j.neuropharm.2022.109300.
   PubMed Web of Science ®Google Scholar
• Barker, S. A. 2018. N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: Past, Present, and future research to determine its role and function. Frontiers in Neuroscience 12:536. doi:10.3389/fnins.2018.00536.
   PubMed Web of Science ®Google Scholar
• Barker, S. A., J. A. Monti, and S. T. Christian. 1981. N, N-dimethyltryptamine: An endogenous hallucinogen. International Review of Neurobiology 22:83–110.
   PubMedGoogle Scholar
• Barrett, F. S., M. W. Johnson, and R. R. Griffiths. 2015. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England) 29 (11):1182–90. doi:10.1177/0269881115609019.
   PubMed Web of Science ®Google Scholar
• Bowles, B., C. Crupi, S. M. Mirsattari, S. E. Pigott, A. G. Parrent, J. C. Pruessner, A. P. Yonelinas, and S. Kohler. 2007. Impaired familiarity with preserved recollection after anterior temporal-lobe resection that spares the hippocampus. Proceedings of the National Academy of Sciences of the United States of America 104 (41):16382–87. doi:10.1073/pnas.0705273104.
   PubMed Web of Science ®Google Scholar
• Breeksema, J. J., and van Elk M. 2021. Working with weirdness: A response to “Moving past mysticism in psychedelic science”. ACS Pharmacology and Translational Science 4:1471–74. doi:10.1021/acsptsci.1c00149.
   PubMedGoogle Scholar
• Carhart-Harris, R. L., K. J. Friston, and E. L. Barker. 2019. REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews 71 (3):316–44. doi:10.1124/pr.118.017160.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., S. Muthukumaraswamy, L. Roseman, M. Kaelen, W. Droog, K. Murphy, E. Tagliazucchi, E. E. Schenberg, T. Nest, C. Orban, et al. 2016. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the United States of America 113 (17):4853–58. doi:10.1073/pnas.1518377113.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., L. Roseman, M. Bolstridge, L. Demetriou, J. N. Pannekoek, M. B. Wall, M. Tanner, M. Kaelen, J. McGonigle, K. Murphy, et al. 2017. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports 7 (1):13187. doi:10.1038/s41598-017-13282-7.
   PubMedGoogle Scholar
• Carhart-Harris, R. L., L. Roseman, E. Haijen, D. Erritzoe, R. Watts, I. Branchi, and M. Kaelen. 2018. Psychedelics and the essential importance of context. Journal of Psychopharmacology (Oxford, England) 32 (7):725–31. doi:10.1177/0269881118754710.
   PubMed Web of Science ®Google Scholar
• Cherniak, A. D., J. G. Brulin, M. Mikulincer, S. Östlind, R. Carhart-Harris, and P. Granqvist. 2022. Psychedelic science of spirituality and religion: An attachment-informed agenda proposal. The International Journal for the Psychology of Religion 1–18. doi:10.1080/10508619.2022.2148061.
   Web of Science ®Google Scholar
• Christian, S. T., R. Harrison, E. Quayle, J. Pagel, and J. Monti. 1977. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochemical Medicine 18 (2):164–83. doi:10.1016/0006-2944(77)90088-6.
   PubMedGoogle Scholar
• Cott, C., and A. Rock. 2008. Phenomenology of N,N-dimethyltryptamine use: A thematic analysis. Journal of Scientific Exploration 22:359–70.
   Google Scholar
• Davis, A. K., J. M. Clifton, E. G. Weaver, E. S. Hurwitz, M. W. Johnson, and R. R. Griffiths. 2020. Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology (Oxford, England) 34 (9):1008–20. doi:10.1177/0269881120916143.
   PubMed Web of Science ®Google Scholar
• Dayton, C. M. 1998. Latent class scaling analysis/C. Mitchell Dayton. Thousand Oaks, CA: Sage Publications. doi:10.4135/9781412984720.
   Google Scholar
• Dean, J. G. 2018. Indolethylamine-N-methyltransferase polymorphisms: Genetic and biochemical approaches for study of endogenous N,N,-dimethyltryptamine. Frontiers in Neuroscience 12:232. doi:10.3389/fnins.2018.00232.
   PubMed Web of Science ®Google Scholar
• Dean, J. G., T. Liu, S. Huff, B. Sheler, S. A. Barker, R. J. Strassman, M. M. Wang, and J. Borjigin. 2019. Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain. Scientific Reports 9 (1):9333. doi:10.1038/s41598-019-45812-w.
   PubMedGoogle Scholar
• Dominguez-Clave, E., J. Soler, J. C. Pascual, M. Elices, A. Franquesa, M. Valle, E. Alvarez, and J. Riba. 2019. Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits. Psychopharmacology (Berl) 236 (2):573–80. doi:10.1007/s00213-018-5085-3.
   PubMed Web of Science ®Google Scholar
• Eichenbaum, H., A. P. Yonelinas, and C. Ranganath. 2007. The medial temporal lobe and recognition memory. Annual Review of Neuroscience 30 (1):123–52. doi:10.1146/annurev.neuro.30.051606.094328.
   PubMed Web of Science ®Google Scholar
• Evans, L. H., and E. L. Wilding. 2012. Recollection and familiarity make independent contributions to memory judgments. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 32 (21):7253–57. doi:10.1523/JNEUROSCI.6396-11.2012.
   PubMed Web of Science ®Google Scholar
• Farovik, A., R. J. Place, D. R. Miller, and H. Eichenbaum. 2011. Amygdala lesions selectively impair familiarity in recognition memory. Nature Neuroscience 14 (11):1416–17. doi:10.1038/nn.2919.
   PubMed Web of Science ®Google Scholar
• Fontanilla, D., M. Johannessen, A. R. Hajipour, N. V. Cozzi, M. B. Jackson, and A. E. Ruoho. 2009. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science: Advanced Materials and Devices 323 (5916):934–37. doi:10.1126/science.1166127.
   Google Scholar
• Fuentes, M., A. Sales, M. Charquero-Ballester, G. Garcia-Marti, J. C. Melendez, R. Espert, M. Scheel, H. C. Bauknecht, K. Simon, U. Kopstein, et al. 2022. Impaired recollection and initially preserved familiarity in a patient with bilateral fornix transection following third ventricle colloid cyst removal: A two-year follow-up study. Applied Neuropsychology Adult 1–13. doi:10.1080/23279095.2022.2104162.
   PubMed Web of Science ®Google Scholar
• Girn, M., F. E. Rosas, R. E. Daws, C. L. Gallen, A. Gazzaley, and R. L. Carhart-Harris. 2023. A complex systems perspective on psychedelic brain action. Trends in Cognitive Sciences 27 (5):433–445. doi:10.1016/j.tics.2023.01.003.
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank, E., K. Heekeren, A. Neukirch, M. Stoll, C. Stock, M. Obradovic, and K. A. Kovar. 2005. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38 (6):301–11. doi:10.1055/s-2005-916185.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., E. S. Hurwitz, A. K. Davis, M. W. Johnson, R. Jesse, and R. Frey. 2019. Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PloS One 14 (4):e0214377. doi:10.1371/journal.pone.0214377.
   PubMed Web of Science ®Google Scholar
• Hartogsohn, I. 2017. Constructing drug effects: A history of set and setting. Drug Science, Policy and Law 3:205032451668332. doi:10.1177/2050324516683325.
   Google Scholar
• Hase, A., M. Erdmann, V. Limbach, and G. Hasler. 2022. Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology (Berl) 239 (2):643–59. doi:10.1007/s00213-022-06062-3.
   PubMed Web of Science ®Google Scholar
• Healy, C. J. 2021. The acute effects of classic psychedelics on memory in humans. Psychopharmacology 238 (3):639–53. doi:10.1007/s00213-020-05756-w.
   PubMed Web of Science ®Google Scholar
• Huxley, A. 1956. Heaven and Hell. United Kingdom: Chatto and Windus.
   Google Scholar
• James, W. 1902. The varieties of religious experience. Oxford University Press. doi:10.1037/10004-000.
   Google Scholar
• Ji, F., A. Amanmyradova, and S. Rabe-Hesketh . 2021. Bayesian latent class models and handling of label switching. Accessed May 2, 2023. https://mc-stan.org/users/documentation/case-studies/Latent_class_case_study.html.
   Google Scholar
• Jimenez, J. H., and J. C. Bouso. 2022. Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate. Journal of Psychopharmacology (Oxford, England) 36 (8):905–19. doi:10.1177/02698811221104054.
   PubMed Web of Science ®Google Scholar
• Kay, M. (2021) _tidybayes: Tidy data and geoms for bayesian models_.
   Google Scholar
• Lawn, W., J. E. Hallak, J. A. Crippa, R. Dos Santos, L. Porffy, M. J. Barratt, J. A. Ferris, A. R. Winstock, and C. J. A. Morgan. 2018. Author correction: Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: A large, international, self-selecting online survey. Scientific Reports 8 (1):4059. doi:10.1038/s41598-018-21666-6.
   PubMedGoogle Scholar
• Lawrence, D. W. 2022. Heart rate (HR) and heart rate variability (HRV) response to inhaled N, N-dimethyltryptamine (N, N-DMT): A case report. Journal of Psychedelic Studies 6 (1):63–68. doi:10.1556/2054.2022.00178.
   Google Scholar
• Lawrence, D. W., R. Carhart-Harris, R. Griffiths, and C. Timmermann. 2022. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Scientific Reports 12 (1):8562. doi:10.1038/s41598-022-11999-8.
   PubMed Web of Science ®Google Scholar
• Luke, D. 2011. Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology, and ontology. Journal of the Society for Psychical Research 75:26–42.
   Google Scholar
• McKenna, D. J., G. H. Towers, and F. Abbott. 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca. Journal of Ethnopharmacology 10 (2):195–223. doi:10.1016/0378-8741(84)90003-5.
   PubMed Web of Science ®Google Scholar
• McKenna, D. J., G. H. Towers, and F. S. Abbott. 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants Part 2: Constituents of orally-active Myristicaceous hallucinogens. Journal of Ethnopharmacology 12 (2):179–211. doi:10.1016/0378-8741(84)90048-5.
   PubMed Web of Science ®Google Scholar
• Medina, J. J. 2008. The biology of recognition memory. Psychiatric Times 13–16.
   Google Scholar
• Michael, P., D. Luke, and O. Robinson. 2021. An encounter with the other: A thematic and content analysis of DMT experiences from a naturalistic field study. Frontiers in Psychology 12:720717. doi:10.3389/fpsyg.2021.720717.
   PubMed Web of Science ®Google Scholar
• Milliere, R., R. L. Carhart-Harris, L. Roseman, F. M. Trautwein, and A. Berkovich-Ohana. 2018. Psychedelics, meditation, and self-consciousness. Frontiers in Psychology 9:1475. doi:10.3389/fpsyg.2018.01475.
   PubMed Web of Science ®Google Scholar
• Muraresku BC (2020) The immortality key: The secret history of the religion with no name. St. Martin’s press
   Google Scholar
• Nichols, D. E. 2018. N,N-dimethyltryptamine and the pineal gland: Separating fact from myth. Journal of Psychopharmacology (Oxford, England) 32 (1):30–36. doi:10.1177/0269881117736919.
   PubMed Web of Science ®Google Scholar
• Nour, M. M., L. Evans, D. Nutt, and R. L. Carhart-Harris. 2016. Ego-dissolution and psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience 10:269. doi:10.3389/fnhum.2016.00269.
   PubMed Web of Science ®Google Scholar
• O’Connor, A. R., and C. J. Moulin. 2008. The persistence of erroneous familiarity in an epileptic male: Challenging perceptual theories of déjà vu activation. Brain & Cognition 68 (2):144–47. doi:10.1016/j.bandc.2008.03.007.
   PubMed Web of Science ®Google Scholar
• Olson, D. E. 2021. The Subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacology and Translational Science 4 (2):563–67. doi:10.1021/acsptsci.0c00192.
   PubMedGoogle Scholar
• Osorio Fde, L., R. F. Sanches, L. R. Macedo, R. G. Santos, J. P. Maia-de-Oliveira, L. Wichert-Ana, D. B. Araujo, J. Riba, J. A. Crippa, and J. E. Hallak. 2015. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira De Psiquiatria 37 (1):13–20. doi:10.1590/1516-4446-2014-1496.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes, F., K. C. Andrade, L. F. Tofoli, A. C. Santos, J. A. Crippa, J. E. Hallak, S. Ribeiro, and de Araujo DB. 2015. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One 10 (2):e0118143. doi:10.1371/journal.pone.0118143.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes, F., D. Barreto, H. Onias, K. C. Andrade, M. M. Novaes, J. A. Pessoa, S. A. Mota-Rolim, F. L. Osorio, R. Sanches, R. G. Dos Santos, et al. 2019. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine 49 (4):655–63. doi:10.1017/S0033291718001356.
   PubMed Web of Science ®Google Scholar
• Pallavicini, C., F. Cavanna, F. Zamberlan, de la Fuente LA, M. Arias, C. Romero, R. Carhart-Harris, C. Timmermann, and E. Tagliazucchi. 2020. Neural and subjective effects of inhaled DMT in natural settings. bioRxiv [Internet].
   Google Scholar
• Pasquini, L., F. Palhano-Fontes, and D. B. Araujo. 2020. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. Journal of Psychopharmacology (Oxford, England) 34 (6):623–35. doi:10.1177/0269881120909409.
   PubMed Web of Science ®Google Scholar
• Potts, M. 2012. Does N,N-dimethyltryptamine (DMT) adequately explain near-death experiences? Journal of Near-Death Studies 31:1–23.
   Google Scholar
• R Development Core Team. 2021. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Riba, J., P. Anderer, A. Morte, G. Urbano, F. Jane, B. Saletu, and M. J. Barbanoj. 2002. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. British Journal of Clinical Pharmacology 53 (6):613–28. doi:10.1046/j.1365-2125.2002.01609.x.
   PubMed Web of Science ®Google Scholar
• Richards, W. A. 2015. Sacred knowledge: Psychedelics and religious experiences. Columbia University Press.
   Google Scholar
• RStudio Team. 2021. RStudio: Integrated development environment for R. Boston, MA: PBC.
   Google Scholar
• Sanches, R. F., F. de Lima Osorio, R. G. Dos Santos, L. R. Macedo, J. P. Maia-de-Oliveira, L. Wichert-Ana, de Araujo DB, J. Riba, J. A. Crippa, and J. E. Hallak. 2016. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology 36:77–81. doi:10.1097/JCP.0000000000000436.
   PubMed Web of Science ®Google Scholar
• Sanders, J. W., and J. Zijlmans. 2021. Moving Past Mysticism in Psychedelic Science. ACS Pharmacology and Translational Science 4 (3):1253–55. doi:10.1021/acsptsci.1c00097.
   PubMedGoogle Scholar
• Santos, R. G., J. Landeira-Fernandez, R. J. Strassman, V. Motta, and A. P. Cruz. 2007. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology 112 (3):507–13. doi:10.1016/j.jep.2007.04.012.
   PubMed Web of Science ®Google Scholar
• Schenberg, E. E., J. F. Alexandre, R. Filev, A. M. Cravo, J. R. Sato, S. D. Muthukumaraswamy, M. Yonamine, M. Waguespack, I. Lomnicka, S. A. Barker, et al. 2015. Acute biphasic effects of ayahuasca. PLoS One 10 (9):e0137202. doi:10.1371/journal.pone.0137202.
   PubMed Web of Science ®Google Scholar
• Seth, A. K., and T. Bayne. 2022. Theories of consciousness. Nature Reviews Neuroscience 23 (7):439–52. doi:10.1038/s41583-022-00587-4.
   PubMed Web of Science ®Google Scholar
• Shanon, B. 2002. The antipodes of the mind: Charting the phenomenology of the ayahuasca experience. Oxford: Oxford Univeristy Press.
   Google Scholar
• Shanon, B. 2008. Biblical entheogens: A speculative hypothesis. Time and Mind: The Journal of Archaeology, Consciousness and Culture 1 (1):51–74. doi:10.2752/175169608783489116.
   Google Scholar
• Speth, J., C. Speth, M. Kaelen, A. M. Schloerscheidt, A. Feilding, D. J. Nutt, and R. L. Carhart-Harris. 2016. Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. Journal of Psychopharmacology (Oxford, England) 30 (4):344–53. doi:10.1177/0269881116628430.
   PubMed Web of Science ®Google Scholar
• Stan Development Team. 2021. Stan modelling language . Accessed May 2, 2023. https://mc-stan.org/.
   Google Scholar
• Strassman, R. J. 2014. DMT and the soul of prophecy: A new science of spiritual revelation in the Hebrew Bible. Rochester: Park Street Press.
   Google Scholar
• Strassman, R. J., C. R. Qualls, E. H. Uhlenhuth, and R. Kellner. 1994. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry 51 (2):98–108. doi:10.1001/archpsyc.1994.03950020022002.
   PubMed Web of Science ®Google Scholar
• Szabo, A., A. Kovacs, J. Riba, S. Djurovic, E. Rajnavolgyi, and E. Frecska. 2016. The endogenous hallucinogen and trace amine N,N-Dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary ipsc-derived cortical neurons and microglia-like immune cells. Frontiers in Neuroscience 10:423. doi:10.3389/fnins.2016.00423.
   PubMed Web of Science ®Google Scholar
• Timmermann, C., H. Kettner, C. Letheby, L. Roseman, F. E. Rosas, and R. L. Carhart-Harris. 2021. Psychedelics alter metaphysical beliefs. Scientific Reports 11 (1):22166. doi:10.1038/s41598-021-01209-2.
   PubMed Web of Science ®Google Scholar
• Timmermann, C. R., S. Rosas, F. Haridas, L. Kettner, H. Luan, J. Errtizoe, D. Martell, E. Pallavacini, C. Tagliazucchi, M. Alamia, et al. 2023. Human Brain Effects of DMT determined via fMRI-EEG. Proceedings of the National Academy of Sciences 120 (13):1–12. doi:10.1073/pnas.2218949120.
   Web of Science ®Google Scholar
• Timmermann, C., L. Roseman, M. Schartner, R. Milliere, L. T. J. Williams, D. Erritzoe, S. Muthukumaraswamy, M. Ashton, A. Bendrioua, O. Kaur, et al. 2019. Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports 9 (1):16324. doi:10.1038/s41598-019-51974-4.
   PubMedGoogle Scholar
• Timmermann, C., L. Roseman, L. Williams, D. Erritzoe, C. Martial, H. Cassol, S. Laureys, D. Nutt, and R. Carhart-Harris. 2018. DMT models the near-death experience. Frontiers in Psychology 9:1424. doi:10.3389/fpsyg.2018.01424.
   PubMed Web of Science ®Google Scholar
• Timmermann, C., R. Watts, and D. Dupuis. 2022. Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. Transcultural Psychiatry 59 (5):691–704. doi:10.1177/13634615221082796.
   PubMed Web of Science ®Google Scholar
• Uthaug, M. V., R. Lancelotta, K. van Oorsouw, K. P. C. Kuypers, N. Mason, J. Rak, A. Sulakova, R. Jurok, M. Maryska, M. Kuchar, et al. 2019. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology (Berl) 236 (9):2653–66. doi:10.1007/s00213-019-05236-w.
   PubMed Web of Science ®Google Scholar
• Valle, M., A. E. Maqueda, M. Rabella, A. Rodriguez-Pujadas, R. M. Antonijoan, S. Romero, J. F. Alonso, M. A. Mananas, S. Barker, P. Friedlander, et al. 2016. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 26 (7):1161–75. doi:10.1016/j.euroneuro.2016.03.012.
   PubMed Web of Science ®Google Scholar
• Voss, J. L., and K. A. Paller. 2017. Neural substrates of remembering: Event-related potential studies. Academic Press. doi:10.1016/B978-0-12-809324-5.21070-5.
   Google Scholar
• Wickham, H. 2016. Ggplot2: Elegant graphics for data analysis. New York: Springer-Verlag. doi:10.1007/978-3-319-24277-4.
   Google Scholar
• Williams, R. A. 2005. Entheogens in the study of religious experiences: Current status. Journal of Religion and Health 44 (4):377–89. doi:10.1007/s10943-005-7177-8.
   Web of Science ®Google Scholar
• Yaden, D. B., and R. R. Griffiths. 2021. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacology and Translational Science 4 (2):568–72. doi:10.1021/acsptsci.0c00194.
   PubMedGoogle Scholar
• Yonelinas, A. P. 2002. The nature of recollection and familiarity: A review of 30 years of research. Journal of Memory and Language 46 (3):441–517. doi:10.1006/jmla.2002.2864.
   Web of Science ®Google Scholar
• Yonelinas, A. P., M. Aly, W. C. Wang, and J. D. Koen. 2010. Recollection and familiarity: Examining controversial assumptions and new directions. Hippocampus 20 (11):1178–94. doi:10.1002/hipo.20864.
   PubMed Web of Science ®Google Scholar
• Yovel, G., and K. A. Paller. 2004. The neural basis of the butcher-on-the-bus phenomenon: When a face seems familiar but is not remembered. Neuroimage 21 (2):789–800. doi:10.1016/j.neuroimage.2003.09.034.
   PubMed Web of Science ®Google Scholar
• Zeifman, R. J., N. Singhal, R. G. Dos Santos, R. F. Sanches, F. de Lima Osorio, J. E. C. Hallak, and C. R. Weissman. 2021. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: Results from an open-label trial. Psychopharmacology (Berl) 238 (2):453–59. doi:10.1007/s00213-020-05692-9.
   PubMed Web of Science ®Google Scholar